Diquafosol tetrasodium
CAS No. 211427-08-6
Diquafosol tetrasodium( INS365 )
Catalog No. M20787 CAS No. 211427-08-6
Diquafosol Tetrasodium is a P2Y2 receptor agonist that stimulates the secretion of mucins from ocular tissues Diquafosol tetrasodium improves tear film stability and visual function as a topical treatment of dry eye disease.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 2MG | 37 | In Stock |
|
| 5MG | 61 | In Stock |
|
| 10MG | 92 | In Stock |
|
| 25MG | 182 | In Stock |
|
| 50MG | 305 | In Stock |
|
| 100MG | 460 | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | 1004 | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameDiquafosol tetrasodium
-
NoteResearch use only, not for human use.
-
Brief DescriptionDiquafosol Tetrasodium is a P2Y2 receptor agonist that stimulates the secretion of mucins from ocular tissues Diquafosol tetrasodium improves tear film stability and visual function as a topical treatment of dry eye disease.
-
DescriptionDiquafosol Tetrasodium is a P2Y2 receptor agonist that stimulates the secretion of mucins from ocular tissues Diquafosol tetrasodium improves tear film stability and visual function as a topical treatment of dry eye disease.
-
In Vitro——
-
In Vivo——
-
SynonymsINS365
-
PathwayNeuroscience
-
TargetP2 Receptor
-
RecptorP2Y2 receptor
-
Research Area——
-
IndicationDiquafosol tetrasodium
Chemical Information
-
CAS Number211427-08-6
-
Formula Weight878.23
-
Molecular FormulaC18H22N4Na4O23P4
-
Purity>98% (HPLC)
-
SolubilityH2O:100 mg/mL (113.87 mM; Need ultrasonic);DMSO:1 mg/mL (1.14 mM; Need ultrasonic)
-
SMILESO=c1ccn(C2OC(COP(=O)([O-])OP(=O)([O-])OP(=O)([O-])OP(=O)([O-])OCC3OC(n4ccc(=O)[nH]c4=O)C(O)C3O)C(O)C2O)c(=O)[nH]1.[Na+].[Na+].[Na+].[Na+]
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Lee J H Lee J S Kim S et al. Comparison of cytotoxicities and wound healing effects of diquafosol tetrasodium and hyaluronic acid on Human corneal epithelial cells[J]. Korean Journal of Physiology and Pharmacology 2017 21(2):189.
molnova catalog
related products
-
Glycitein
Glycitein inhibits glioma cell invasion through down-regulation of MMP-3 and MMP-9 gene expression.
-
BAY-1797
BAY-1797 is an orally active and selective P2X4 antagonist (IC50: 211 nM against human P2X4) with anti-nociceptive and anti-inflammatory effects.
-
JNJ-47965567
JNJ-47965567 is a selective antagonist of the purinergic receptor P2X subtype 7 (P2X7), a ligand-gated ion channel(with pKis of 7.9 and 8.7 for human and rat P2X7, respectively).
Cart
sales@molnova.com